Obesity
Hannah Dugan
Fbi
Law Enforcement
Donald Trump
Together For Germany
Society Of Environmental Journalists
Undocumented Immigrant
Ukraine Aid
Antisemitism
Barack Obama
Obesity
New York Post - Mar 29th, 2025
Bizarre NYC pizza ad that name-drops Wegovy is is sparking outrage: ‘This is crazy’
NYC pizza-bagel shop's weight-loss drug ad sparks outrage and debate.
Pr Newswire - Dec 18th, 2024
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous (SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily),...
Previous
Next
Showing 1 to 2 of 2 results